Outcome Health LLC
Healthcare advertising startup whose founders were criminally convicted of wire fraud for selling nonexistent advertising screens and fabricating ad metrics.
- Entity Name: Outcome Health LLC
- Country of Domicile: US
- Listing & Ticker: Private.
- CIK / LEI Identifier: Unregistered.
- Industry Classification: Advertising Agencies (SIC 7311).
- Cumulative Overstatement: $1.0B across 1 enforcement episode(s).
- Assessed Penalties: $70.0M.
PRIMARY ENFORCEMENT CASES INVOLVING OUTCOME HEALTH LLC
1 CASE DOSSIERS| Case Title | Status | Primary Scheme | Overstatement | Total Penalties | Action Date |
|---|---|---|---|---|---|
| Outcome Health: $1B Deceptive Pharmaceutical Advertising Analytics and Screen Count Fraud | Adjudicated | fictitious revenue | $1.0B | $70.0M | September 20, 2019 |
FORENSIC PROFILE: OUTCOME HEALTH: $1B DECEPTIVE PHARMACEUTICAL ADVERTISING ANALYTICS AND SCREEN COUNT FRAUD
FULL CASE DOSSIER →Sold pharmaceutical advertising inventory on doctor waiting room screens that did not exist, inflating delivery metrics to fraudulently raise $1B from investors including Google and Goldman Sachs.
The company manipulated its accounting records by executing schemes under fictitious-revenue. Financial reports filed with market regulators contained material misstatements that distorted true financial condition.
Fraud Window: January 1, 2017 to December 31, 2019 • Primary Regulator: U.S. Securities and Exchange Commission • Auditor: KPMG LLP
Documented Accounting Irregularities & Regulatory Findings
- FICTITIOUS REVENUE: Sold pharmaceutical advertising inventory on doctor waiting room screens that did not exist, inflating delivery metrics to fraudulently raise $1B from investors including Google and Goldman Sachs.
Primary Public Dockets & Actions
- [ENF-2017-outcome-health] Enforcement Action: Outcome Health: $1B Deceptive Pharmaceutical Advertising Analytics and Screen Count Fraud (September 20, 2019): Sold pharmaceutical advertising inventory on doctor waiting room screens that did not exist, inflating delivery metrics to fraudulently raise $1B from investors including Google and Goldman Sachs. Official Record ↗